Terms: = Germ cell tumor AND FGFR3, CD333, 2261, ENSG00000068078, P22607, JTK4, ACH, HSFGFR3EX, CEK2
186 results:
1. Exploration of functional relations among differentially co-expressed genes identifies regulators in glioblastoma.
Kumar S; Sarmah DT; Paul A; Chatterjee S
Comput Biol Chem; 2024 Apr; 109():108024. PubMed ID: 38335855
[TBL] [Abstract] [Full Text] [Related]
2. Feasibility and antitumour activity of the FGFR inhibitor erdafitnib in three paediatric CNS tumour patients.
Stepien N; Mayr L; Schmook MT; Raimann A; Dorfer C; Peyrl A; Azizi AA; Schramm K; Haberler C; Gojo J
Pediatr Blood Cancer; 2024 Mar; 71(3):e30836. PubMed ID: 38177074
[TBL] [Abstract] [Full Text] [Related]
3. Systematic review and cumulative analysis of clinical properties of BRAF V600E mutations in PLNTY histological samples.
Baumgartner ME; Lang SS; Tucker AM; Madsen PJ; Storm PB; Kennedy BC
Childs Nerv Syst; 2024 May; 40(5):1361-1366. PubMed ID: 38150037
[TBL] [Abstract] [Full Text] [Related]
4. Clinical significance of molecular subgroups of polymorphous low-grade neuroepithelial tumor of the young (PLNTY): A small single institutional case series and integrated analysis.
Vuong HG; Alzayadneh E; Reith TP; Eschbacher KL
Pathol Res Pract; 2023 Dec; 252():154922. PubMed ID: 37984047
[TBL] [Abstract] [Full Text] [Related]
5. Network pharmacology-based analysis of Jin-Si-Wei on the treatment of Alzheimer's disease.
Zhi J; Yin L; Zhang Z; Lv Y; Wu F; Yang Y; Zhang E; Li H; Lu N; Zhou M; Hu Q
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117291. PubMed ID: 37925002
[TBL] [Abstract] [Full Text] [Related]
6. Ethanolic Extract of
Sayuti NH; Zulkefli N; Tan JK; Saad N; Baharum SN; Hamezah HS; Bunawan H; Ahmed QU; Parveen H; Mukhtar S; Alsharif MA; Sarian MN
Molecules; 2023 Sep; 28(18):. PubMed ID: 37764502
[TBL] [Abstract] [Full Text] [Related]
7. Unraveling the Mystery: Next Generation Sequencing Sheds Light on Neuroblastoma Pathogenesis and Targeted Therapies.
Aktas T; Kızmazoglu D; Aktas S; Erol A; Serinan E; Gokbayrak O; Ozdemir SM; Altun Z; Ozer E; Cecen E; Ince D; Olgun N
Front Biosci (Landmark Ed); 2023 Aug; 28(8):171. PubMed ID: 37664946
[TBL] [Abstract] [Full Text] [Related]
8. Discovery of Multitarget-Directed Ligands from Piperidine Alkaloid Piperine as a Cap Group for the Management of Alzheimer's Disease.
Bhanukiran K; Singh SK; Singh R; Kumar A; Hemalatha S
ACS Chem Neurosci; 2023 Aug; 14(15):2743-2760. PubMed ID: 37433759
[TBL] [Abstract] [Full Text] [Related]
9. A diffuse glioma with oligodendroglial-like cells and extensive calcifications.
Martelli FM; Marastoni E; Barresi V
Brain Pathol; 2024 Jan; 34(1):e13187. PubMed ID: 37409721
[TBL] [Abstract] [Full Text] [Related]
10. Evaluation of 4-aminoquinoline derivatives with an n-octylamino spacer as potential multi-targeting ligands for the treatment of Alzheimer's disease.
Matošević A; Opsenica DM; Spasić M; Maraković N; Zandona A; Žunec S; Bartolić M; Kovarik Z; Bosak A
Chem Biol Interact; 2023 Sep; 382():110620. PubMed ID: 37406982
[TBL] [Abstract] [Full Text] [Related]
11. Differentiated SH-SY5Y neuroblastoma cells as a model for evaluation of nerve agent-associated neurotoxicity.
Pulkrabkova L; Muckova L; Hrabinova M; Sorf A; Kobrlova T; Jost P; Bezdekova D; Korabecny J; Jun D; Soukup O
Arch Toxicol; 2023 Aug; 97(8):2209-2217. PubMed ID: 37221426
[TBL] [Abstract] [Full Text] [Related]
12. Epigenetic Alteration of H3K27me3 as a Possible Oncogenic Mechanism of Central Neurocytoma.
Kim H; Lee K; Shim YM; Kim EE; Kim SK; Phi JH; Park CK; Choi SH; Park SH
Lab Invest; 2023 Aug; 103(8):100159. PubMed ID: 37088465
[TBL] [Abstract] [Full Text] [Related]
13. Predictive biomarkers of immunotherapy response with pharmacological applications in solid tumors.
Kovács SA; Fekete JT; Győrffy B
Acta Pharmacol Sin; 2023 Sep; 44(9):1879-1889. PubMed ID: 37055532
[TBL] [Abstract] [Full Text] [Related]
14. Thymic atypical carcinoid tumors with elevated mitotic counts in a patient with multiple endocrine neoplasia: A case report.
Hiro S; Teranishi S; Sawazumi T; Nagaoka S; Sugimoto C; Nagayama H; Segawa W; Kajita Y; Maeda C; Kubo S; Seki K; Tashiro K; Kobayashi N; Yamamoto M; Kudo M; Kaneko T
Thorac Cancer; 2023 May; 14(14):1311-1315. PubMed ID: 36941083
[TBL] [Abstract] [Full Text] [Related]
15. Discovery of multi-target directed 3-OH pyrrolidine derivatives through a semisynthetic approach from alkaloid vasicine for the treatment of Alzheimer's disease.
Bhanukiran K; T A G; Krishnamurthy S; Singh SK; Hemalatha S
Eur J Med Chem; 2023 Mar; 249():115145. PubMed ID: 36706620
[TBL] [Abstract] [Full Text] [Related]
16. Clinico-pathological and epigenetic heterogeneity of diffuse gliomas with fgfr3::TACC3 fusion.
Métais A; Tauziède-Espariat A; Garcia J; Appay R; Uro-Coste E; Meyronet D; Maurage CA; Vandenbos F; Rigau V; Chiforeanu DC; Pallud J; Senova S; Saffroy R; Colin C; Edjlali M; Varlet P; Figarella-Branger D;
Acta Neuropathol Commun; 2023 Jan; 11(1):14. PubMed ID: 36647073
[TBL] [Abstract] [Full Text] [Related]
17. Lung cancer presenting with central nervous system metastasis: Clinicopathological and molecular analysis of 171 cases.
Demleitner M; Erlenbach-Wünsch K; Coras R; Erber R; Polifka I; Eyüpoğlu I; Fuchs F; Hartmann A; Agaimy A
Ann Diagn Pathol; 2023 Apr; 63():152082. PubMed ID: 36634550
[TBL] [Abstract] [Full Text] [Related]
18. Functionalised penetrating peptide-chondroitin sulphate‑gold nanoparticles: Synthesis, characterization, and applications as an anti-Alzheimer's disease drug.
Feng Y; Li X; Ji D; Tian J; Peng Q; Shen Y; Xiao Y
Int J Biol Macromol; 2023 Mar; 230():123125. PubMed ID: 36603725
[TBL] [Abstract] [Full Text] [Related]
19. Infiltrating gliomas with FGFR alterations: Histologic features, genetic alterations, and potential clinical implications.
Dono A; El Achi H; Bundrant BE; Goli PS; Zhu P; Ozkizilkaya HI; Esquenazi Y; Ballester LY
Cancer Biomark; 2023; 36(2):117-131. PubMed ID: 36530080
[TBL] [Abstract] [Full Text] [Related]
20. Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterations.
Murugesan K; Necchi A; Burn TC; Gjoerup O; Greenstein R; Krook M; López JA; Montesion M; Nimeiri H; Parikh AR; Roychowdhury S; Schwemmers S; Silverman IM; Vogel A
ESMO Open; 2022 Dec; 7(6):100641. PubMed ID: 36462464
[TBL] [Abstract] [Full Text] [Related]
[Next]
